Epigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes

Cancer Research

Volumn 66, Issue 18, 2006, Pages 9125-9133

  Osanai, Makoto ^a   Murata, Masaki ^a   Nishikiori, Nami ^a   Chiba, Hideki ^a   Kojima, Takashi ^a   Sawada, Norimasa ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CISPLATIN; ETOPOSIDE; HISTONE DEACETYLASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; OCCLUDIN; RETINOIC ACID RECEPTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENIC ACTIVITY; CELL INVASION; CELL MOTILITY; CELL TRANSFORMATION; CONTROLLED STUDY; DELETION MUTANT; DRUG EFFECT; EPIGENETICS; GENE SILENCING; HUMAN; HUMAN CELL; MALE; METASTASIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HELA CELLS; HUMANS; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; NEOPLASMS; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION; TRETINOIN;

EID: 33749484749     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-1864     Document Type: Article

References (43)

1. Schneeberger EE, Lynch RD. Structure, function, and regulation of cellular tight junctions. Am J Physiol 1992;262:L647-61.
2. Gumbiner EE. Breaking through the tight junction barrier. J Cell Biol 1993;123:1631-3.
3. Furuse M, Hirase T, Itoh M, et al. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993;123:1777-88.
4. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001;2:285-93.
5. Tsukita S, Furuse M. Overcoming barriers in the study of tight junction function: from occludin to claudin. Genes Cells 1998;3:569-73.
6. Saitou M, Fujimoto K, Doi Y, et al. Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J Cell Biol 1998;141:397-408.
7. Saitou M, Furuse M, Sasaki H, et al. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 2000;11:4131-42.
8. Matter K, Balda MS. Signalling to and from tight junctions. Nat Rev Mol Cell Biol 2003;4:225-36.
9. Balda MS, Matter K. The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression. EMBO J 2000;19:2024-33.
10. Chen YH, Lu Q, Goodenough DA, et al. Nonreceptor tyrosine kinase c-yes interacts with occludin during tight junction formation in canine kidney epithelial cells. Mol Biol Cell 2002;13:1227-37.
11. Betanzos A, Huerta M, Lopez-Bayghen E, et al. The tight junction protein ZO-2 associates with Jun, Fos and C/EBP transcription factors in epithelial cells. Exp Cell Res 2004;392:51-66.
12. Murata M, Kojima T, Yamamoto T, et al. Downregulation of survival signaling through MAPK and Akt in occludin-deficient mouse hepatocytes in vitro. Exp Cell Res 2005;310:140-51.
13. Tobioka H, Isomura H, Kokai Y, et al. Occludin expression decreases with the progression of human endometrial carcinoma. Hum Pathol 2004;35:159-64.
14. Kimura Y, Shiozald H, Hirao M, et al. Expression of occludin, tight-junction-associated protein, in human digestive tract. Am J Pathol 1997;151:45-54.
15. Li D, Mrsny RJ. Oncogenic Raf-1 disrupts epithelial tight junctions via downregulation of occludin. J Cell Biol 2000;148:791-800.
16. Wang Z, Mandell KJ, Parkos CA, et al. The second loop of occludin is required for suppression of Raf-1-induced tumor growth. Oncogene 2005;24:4412-20.
17. Michl P, Barth C, Buchholz M, et al. Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res 2003;63:6265-71.
18. Mima S, Tsutsumi S, Ushijima H, et al. Induction of claudin-4 by nonsteroidal anti-inflammatory drugs and its contribution to their chemopreventive effect Cancer Res 2005;65:1868-76.
19. Hoevel T, Macek R, Swisshelm K, et al. Reexpression of the TJ protein CLDN1 induces apoptosis in breast tumor spheroids. Int J Cancer 2004;108:374-83.
20. Elliott BE, Maxwell L, Arnold M, et al. Expression of epithelial-like markers and class-I major histocompatibility antigens by a murine carcinoma growing in the mammary gland and in metastases: orthotopic site effects. Cancer Res 1988;48:7237-45.
21. Osanai M, Petkovich M. Expression of the retinoic acid-metabolizing enzyme CYP26AI limits programmed cell death. Mol Pharmacol 2005;67:1808-17.
22. Osanai M, Chiba H, Kojima T, et al. Hepatocyte nuclear factor (HNF)-4α induces expression of endothelial Fas ligand (FasL) to prevent cancer cell transmigration: a novel defense mechanism of endothelium against cancer metastasis. Jpn J Cancer Res 2002;93:532-41.
23. Clark SJ, Harrison J, Paul CL, et al. High sensitivity mapping of methylated cytosines. Nucleic Acid Res 1994;22:2990-7.
24. Kubota H, Chiba H, Takakuwa Y, et al. Retinoid X receptor α and retinoic acid receptor γ mediate expression of genes encoding tight-junction proteins and barrier function in F9 cells during visceral endodermal differentiation. Exp Cell Res 2001;263:163-72.
25. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004;4:988-93.
26. Ding S, Gong BD, Yu J, et al. Methylation profile of the promoter CpG islands of 14 drug-resistance genes in hepatocellular carcinoma. World J Gastroenterol 2004;10:3433-40.
27. Bordin, M, D'Atri F, Guillemot L, et al. Histone deacetylase inhibitors up-regulate the expression of tight junction proteins. Mol Cancer Res 2004;2:692-701.
28. Cameron EE, Bachman KE, Myöhänen S, et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999;21:103-7.
29. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell 1994;78:539-42.
30. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001;411:342-8.
31. Green DR, Evan GI. A matter of life and death. Cancer Cell 2002;1:19-30.
32. Gozani O, Boyce M, Yoo L, et al. Life and death in paradise. Nat Cell Biol 2002;4:E159-62.
33. Bogenrieder T, Herlyn M. Axis of devil: molecular mechanisms of cancer metastasis. Oncogene 2003;22:6524-36.
34. Matter K, Aijaz S, Tsapara A, at al. Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Curr Opin Cell Biol 2005;17:1-6.
35. Nusrat A, Chen JA, Foley CS, et al. The coiled-coil domain of occludin can act to organize structural and functional elements of the epithelial tight junction. J Biol Chem 2000;275:29816-22.
36. Sheth P, Basuroy S, Li C, et al. Role of phosphatidylinositol 3-kinase in oxidative-stress-induced disruption of tight junctions. J Biol Chem 2003;278:49239-45.
37. Sharma GD, He J, Bazan HE. p38 and ERK1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP kinase cascades. J Biol Chem 2003;278:21989-97.
38. Barrios-Rodiles M, Brown KR, Ozdamar B, et al. High-throughput mapping of a dynamic signaling network in mammalian cells. Science 2005;307:1621-5.
39. Castro PD, Fairman J, Nagarajan L. The unexplored 5q13 locus: a role in hematopoietic malignancies. Leuk Lymphoma 1998;30:443-8.
40. Wu X, Zhao Y, Kemp BL, et al. Chromosome 5 aberrations and genetic predisposition to lung cancer. Int J Cancer 1998;79:490-3.
41. Castro PD, Liang JC, Nagarajan L. Deletion of chromosome 5q13.3 and 17q loci cooperates in myeloid neoplasms. Blood 2000;95:2138-43.
42. Lotan R. Retinoids in cancer chemoprevention. FASEB J 1996;10:1031-9.
43. Hong WK, Sporn MB. Recent advances in chemoprevention of cancer. Science 1997;278:1073-7.